Literature DB >> 15683114

Use of complementary and alternative medicine among Korean cancer patients.

Min Jae Kim1, Sang Dae Lee, Duck Ryung Kim, Yun Ho Kong, Wee Sik Sohn, Seung Seog Ki, Jin Kim, Yu Cheol Kim, Chul Ju Han, Jin Oh Lee, Hyeon-Seok Nam, Yeon-Hee Park, Cheol Hyeon Kim, Ka-Hee Yi, Yoon Yong Lee, Sook-Hyang Jeong.   

Abstract

BACKGROUND: Complementary and alternative medicine (CAM) is now being increasingly used among cancer patients. The objectives of our study were to assess the prevalence, types, cost, subjective effects, and side effects of CAM use, reasons for CAM use, characteristics of CAM users compared to those of nonusers, and patients' expectations of doctors regarding their CAM use among Korean cancer patients at a single cancer center.
METHODS: From April to August, 2003, we interviewed 186 cancer patients hospitalized in the Korea Cancer Center Hospital using a structured questionnaire, and analyzed the data.
RESULTS: 78.5% of experimental subjects (146 patients) had been treated with at least one type of CAM, in addition to conventional Western treatment, with a mean monthly cost of 1,380,000 Won/person (approximately, 1,100 U.S. dollars on July, 2004). The most prevalent types of CAM used by these patients included medicinal mushrooms (67.1%), herbs (54.1%), vegetable diets (50.6%), and ginseng (46.5%). The main reported reasons for the use of CAM in addition to conventional medicine were nutritional support (19.1%) and physical strengthening (17.8%). 5% of CAM users experienced side effects. The younger and more educated the patients were, the more likely they were to employ CAM. 66% of CAM users wanted to discuss CAM techniques with their doctors.
CONCLUSION: More than two-thirds of cancer patients used various kinds of CAM, incurring considerable costs. Therefore, in order to help patients make informed decisions, medical society should be open to communication with patients. Not only the scientific aspects, but also the economic aspects of CAM usage should be examined more thoroughly, in order to ensure proper distribution of medical resources.

Entities:  

Mesh:

Year:  2004        PMID: 15683114      PMCID: PMC4531582          DOI: 10.3904/kjim.2004.19.4.250

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  15 in total

Review 1.  Complementary and alternative cancer medicine.

Authors:  B R Cassileth
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

Review 2.  "Alternative medicine" and the cancer patient: an overview.

Authors:  J M Metz
Journal:  Med Pediatr Oncol       Date:  2000-01

3.  Use of complementary medicine by adult patients participating in cancer clinical trials.

Authors:  A Sparber; L Bauer; G Curt; D Eisenberg; T Levin; S Parks; S M Steinberg; J Wootton
Journal:  Oncol Nurs Forum       Date:  2000-05       Impact factor: 2.172

4.  The prevalence of questionable methods of cancer treatment in the United States.

Authors:  I J Lerner; B J Kennedy
Journal:  CA Cancer J Clin       Date:  1992 May-Jun       Impact factor: 508.702

5.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Advising patients who seek complementary and alternative medical therapies for cancer.

Authors:  Wendy A Weiger; Michael Smith; Heather Boon; Mary Ann Richardson; Ted J Kaptchuk; David M Eisenberg
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

7.  Patterns of alternative medicine use by cancer patients.

Authors:  S D Begbie; Z L Kerestes; D R Bell
Journal:  Med J Aust       Date:  1996-11-18       Impact factor: 7.738

8.  Cross sectional study of use of alternative medicines in Chinese cancer patients.

Authors:  J M Liu; H C Chu; Y H Chin; Y M Chen; R K Hsieh; T J Chiou; J Whang-Peng
Journal:  Jpn J Clin Oncol       Date:  1997-02       Impact factor: 3.019

9.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

10.  Alternative care. Patient choices for adjunct therapies within a cancer center.

Authors:  R A Coss; P McGrath; V Caggiano
Journal:  Cancer Pract       Date:  1998 May-Jun
View more
  10 in total

1.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

Review 2.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

3.  Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.

Authors:  Koji Yoshimura; Nobufumi Ueda; Kentaro Ichioka; Yoshiyuki Matsui; Akito Terai; Yoichi Arai
Journal:  Support Care Cancer       Date:  2005-06-10       Impact factor: 3.603

4.  Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine.

Authors:  Do Yeun Kim; Bong-Seog Kim; Kyung Hee Lee; Myung Ah Lee; Young Seon Hong; Sang Won Shin; Soon Nam Lee
Journal:  Cancer Res Treat       Date:  2008-06-30       Impact factor: 4.679

5.  Use of Chinese medicine by cancer patients: a review of surveys.

Authors:  Bridget Carmady; Caroline A Smith
Journal:  Chin Med       Date:  2011-06-09       Impact factor: 5.455

6.  Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study.

Authors:  Jung Hye Hwang; Hyun Jeong Cho; Hyea Bin Im; Young Sun Jung; Soo Jeung Choi; Dongwoon Han
Journal:  BMC Complement Med Ther       Date:  2020-05-13

Review 7.  The effects of beta-glucan on human immune and cancer cells.

Authors:  Godfrey Chi-Fung Chan; Wing Keung Chan; Daniel Man-Yuen Sze
Journal:  J Hematol Oncol       Date:  2009-06-10       Impact factor: 17.388

8.  Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians.

Authors:  Jennifer L McQuade; Zhiqiang Meng; Zhen Chen; Qi Wei; Ying Zhang; Wenying Bei; J Lynn Palmer; Lorenzo Cohen
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-11       Impact factor: 2.629

9.  The use of health functional foods in gastrointestinal cancer patients.

Authors:  Hwa Pyoung Kang; Hosun Lee; Tak Geun Oh; Kyong Joo Lee; Soo Jung Park; Moon Jae Chung; Seung Up Kim; Hyuk Lee; Jun Chul Park; Sung Pil Hong; Jun Yong Park; Jeong Youp Park; Seungmin Bang; Do Young Kim; Jae Hee Cheon; Sang Hoon Ahn; Tae Il Kim; Seung Woo Park; Si Young Song
Journal:  Clin Nutr Res       Date:  2013-01-29

10.  Acupuncture and herbal medicine for cancer patients.

Authors:  S Schröder; S Lee; T Efferth; Y Motoo
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-25       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.